Pentoxyresorufin | CAS#87687-03-4 | CYP substrate

MedKoo Cat#: 112159 | Name: Pentoxyresorufin

Featured

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Pentoxyresorufin is a fluorogenic substrate for cytochrome P450 (CYP) enzymes.

Chemical Structure

Pentoxyresorufin

CAS#87687-03-4

Theoretical Analysis

MedKoo Cat#: 112159

Name: Pentoxyresorufin

CAS#: 87687-03-4

Chemical Formula: C17H17NO3

Exact Mass: 283.1208

Molecular Weight: 283.33

Elemental Analysis: C, 72.07; H, 6.05; N, 4.94; O, 16.94

Price and Availability

Size	Price	Availability	Quantity
10mg	USD 550.00	2 Weeks

Bulk Inquiry

Buy Now

Add to Cart

Related CAS #

No Data

Synonym

Pentoxyresorufin; 7-Pentoxyresorufin; O-Pentylresorufin

IUPAC/Chemical Name

7-(pentyloxy)-3H-phenoxazin-3-one

InChi Key

ZPSOKQFFOYYPKC-UHFFFAOYSA-N

InChi Code

InChI=1S/C17H17NO3/c1-2-3-4-9-20-13-6-8-15-17(11-13)21-16-10-12(19)5-7-14(16)18-15/h5-8,10-11H,2-4,9H2,1H3

SMILES Code

O=C1C=CC2=NC3=C(OC2=C1)C=C(C=C3)OCCCCC

Appearance

Solid powder

Purity

>95% (or refer to the Certificate of Analysis)

Shipping Condition

Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition

Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility

To be determined

Shelf Life

>2 years if stored properly

Drug Formulation

To be determined

Stock Solution Storage

0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code

2934.99.9001

More Info

Instruction

View handling instruction

Preparing Stock Solutions

The following data is based on the product molecular weight 283.33 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Concentration / Solvent Volume / Mass	1 mg	5 mg	10 mg
1 mM	1.15 mL	5.76 mL	11.51 mL
5 mM	0.23 mL	1.15 mL	2.3 mL
10 mM	0.12 mL	0.58 mL	1.15 mL
50 mM	0.02 mL	0.12 mL	0.23 mL

1: Koponen M, Rysä J, Ruotsalainen AK, Kärkkäinen O, Juvonen RO. Western Diet Decreases Hepatic Drug Metabolism in Male LDLr-/-ApoB100/100 Mice. J Nutr Metab. 2023 Mar 31;2023:5599789. doi: 10.1155/2023/5599789. PMID: 37034183; PMCID: PMC10081903. 2: Shinya S, Yohannes YB, Ikenaka Y, Nakayama SM, Ishizuka M, Fujita S. Characteristics of cytochrome P450-dependent metabolism in the liver of the wild raccoon, Procyon lotor. J Vet Med Sci. 2022 Dec 14;84(12):1665-1672. doi: 10.1292/jvms.22-0182. Epub 2022 Nov 2. PMID: 36328483; PMCID: PMC9791232. 3: Uehara S, Murayama N, Higuchi Y, Yoneda N, Yamazaki H, Suemizu H. Comparison of mouse and human cytochrome P450 mediated-drug metabolising activities in hepatic and extrahepatic microsomes. Xenobiotica. 2022 Mar;52(3):229-239. doi: 10.1080/00498254.2022.2066581. Epub 2022 Apr 26. PMID: 35416115. 4: Uehara S, Yoneda N, Higuchi Y, Yamazaki H, Suemizu H. Cytochrome P450-dependent drug oxidation activities and their expression levels in liver microsomes of chimeric TK-NOG mice with humanized livers. Drug Metab Pharmacokinet. 2022 Jun;44:100454. doi: 10.1016/j.dmpk.2022.100454. Epub 2022 Feb 25. PMID: 35378494. 5: Xin Q, Li H, Yuan M, Song X, Jing T. Effects of Echinococcus multilocularis metacestodes infection and drug treatment on the activities of biotransformation enzymes in mouse liver. Parasitol Int. 2022 Aug;89:102563. doi: 10.1016/j.parint.2022.102563. Epub 2022 Feb 22. PMID: 35202818. 6: Juvonen RO, Ahinko M, Jokinen EM, Huuskonen J, Raunio H, Pentikäinen OT. Substrate Selectivity of Coumarin Derivatives by Human CYP1 Enzymes: In Vitro Enzyme Kinetics and In Silico Modeling. ACS Omega. 2021 Apr 19;6(17):11286-11296. doi: 10.1021/acsomega.1c00123. PMID: 34056284; PMCID: PMC8153946. 7: Alarcón S, Esteban J, Roos R, Heikkinen P, Sánchez-Pérez I, Adamsson A, Toppari J, Koskela A, Finnilä MAJ, Tuukkanen J, Herlin M, Hamscher G, Leslie HA, Korkalainen M, Halldin K, Schrenk D, Håkansson H, Viluksela M. Endocrine, metabolic and apical effects of in utero and lactational exposure to non-dioxin- like 2,2',3,4,4',5,5'-heptachlorobiphenyl (PCB 180): A postnatal follow-up study in rats. Reprod Toxicol. 2021 Jun;102:109-127. doi: 10.1016/j.reprotox.2021.04.004. Epub 2021 May 13. PMID: 33992733. 8: Bozcaarmutlu A, Sapmaz C, Bozdoğan Ö, Kükner A, Kılınç L, Kaya ST, Özarslan OT, Ekşioğlu D. The effect of co-administration of berberine, resveratrol, and glibenclamide on xenobiotic metabolizing enzyme activities in diabetic rat liver. Drug Chem Toxicol. 2022 May;45(3):990-998. doi: 10.1080/01480545.2020.1802475. Epub 2020 Aug 6. PMID: 32762264. 9: Chorley BN, Carswell GK, Nelson G, Bhat VS, Wood CE. Early microRNA indicators of PPARα pathway activation in the liver. Toxicol Rep. 2020 Jun 23;7:805-815. doi: 10.1016/j.toxrep.2020.06.006. PMID: 32642447; PMCID: PMC7334544. 10: Lake BG, Price RJ, Scott MP, Chatham LR, Vardy A, Osimitz TG. Piperonyl butoxide: Mode of action analysis for mouse liver tumour formation and human relevance. Toxicology. 2020 Jun;439:152465. doi: 10.1016/j.tox.2020.152465. Epub 2020 Apr 19. PMID: 32320717. 11: Ibor OR, Eni G, Andem AB, Bassey IU, Arong GA, Asor J, Regoli F, Arukwe A. Biotransformation and oxidative stress responses in relation to tissue contaminant burden in Clarias gariepinus exposed to simulated leachate from a solid waste dumpsite in Calabar, Nigeria. Chemosphere. 2020 Aug;253:126630. doi: 10.1016/j.chemosphere.2020.126630. Epub 2020 Apr 3. PMID: 32278189. 12: Goettel M, Fegert I, Honarvar N, Vardy A, Haines C, Chatham LR, Lake BG. Comparative studies on the effects of sodium phenobarbital and two other constitutive androstane receptor (CAR) activators on induction of cytochrome P450 enzymes and replicative DNA synthesis in cultured hepatocytes from wild type and CAR knockout rats. Toxicology. 2020 Mar 30;433-434:152394. doi: 10.1016/j.tox.2020.152394. Epub 2020 Feb 3. PMID: 32027962. 13: Ryu CS, Choi YJ, Nam HS, Jeon JS, Jung T, Park JE, Choi SJ, Lee K, Lee MY, Kim SK. Short-term regulation of the hepatic activities of cytochrome P450 and glutathione S-transferase by nose-only cigarette smoke exposure in mice. Food Chem Toxicol. 2019 Mar;125:182-189. doi: 10.1016/j.fct.2018.12.035. Epub 2019 Jan 3. PMID: 30610934. 14: Wu GJ, Lin YW, Tsai HC, Lee YW, Chen JT, Chen RM. Sepsis-induced liver dysfunction was ameliorated by propofol via suppressing hepatic lipid peroxidation, inflammation, and drug interactions. Life Sci. 2018 Nov 15;213:279-286. doi: 10.1016/j.lfs.2018.10.038. Epub 2018 Oct 21. PMID: 30352244. 15: Dong H, Lu G, Yan Z, Liu J, Nkoom M, Yang H. Responses of antioxidant and biotransformation enzymes in Carassius carassius exposed to hexabromocyclododecane. Environ Toxicol Pharmacol. 2018 Sep;62:46-53. doi: 10.1016/j.etap.2018.06.009. Epub 2018 Jun 25. PMID: 29960092. 16: Yang JD, Liu SH, Liao MH, Chen RM, Liu PY, Ueng TH. Effects of tebuconazole on cytochrome P450 enzymes, oxidative stress, and endocrine disruption in male rats. Environ Toxicol. 2018 Jun 19. doi: 10.1002/tox.22575. Epub ahead of print. PMID: 29923317. 17: Martínez MA, Ares I, Rodríguez JL, Martínez M, Roura-Martínez D, Castellano V, Lopez-Torres B, Martínez-Larrañaga MR, Anadón A. Pyrethroid insecticide lambda-cyhalothrin induces hepatic cytochrome P450 enzymes, oxidative stress and apoptosis in rats. Sci Total Environ. 2018 Aug 1;631-632:1371-1382. doi: 10.1016/j.scitotenv.2018.03.030. Epub 2018 Mar 28. PMID: 29727961. 18: Oshio T, Uehara S, Uno Y, Inoue T, Sasaki E, Yamazaki H. Marmoset cytochrome P450 2B6, a propofol hydroxylase expressed in liver. Xenobiotica. 2019 Mar;49(3):265-269. doi: 10.1080/00498254.2018.1439204. Epub 2018 Feb 21. PMID: 29417863. 19: LaRocca JL, Rasoulpour RJ, Gollapudi BB, Eisenbrandt DL, Murphy LA, LeBaron MJ. Integration of novel approaches demonstrates simultaneous metabolic inactivation and CAR-mediated hepatocarcinogenesis of a nitrification inhibitor. Toxicol Rep. 2017 Oct 28;4:586-597. doi: 10.1016/j.toxrep.2017.10.007. PMID: 29159133; PMCID: PMC5684092. 20: Miyajima A, Sakemi-Hoshikawa K, Usami M, Mitsunaga K, Irie T, Ohno Y, Sunouchi M. Thyrotoxic rubber antioxidants, 2-mercaptobenzimidazole and its methyl derivatives, cause both inhibition and induction of drug-metabolizing activity in rat liver microsomes after repeated oral administration. Biochem Biophys Res Commun. 2017 Oct 7;492(1):116-120. doi: 10.1016/j.bbrc.2017.08.024. Epub 2017 Aug 9. PMID: 28800917.